Drug development: Longer-lived proteins

Nature

Volumn 467, Issue 7319, 2010, Pages 1051-1052

  Hubbell, Jeffrey A ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; POLYMER; RECOMBINANT PROTEIN;

AMINO ACID; DRUG; ENZYME ACTIVITY; GENETIC ENGINEERING; HORMONE; HYDRODYNAMICS; METABOLISM; NUMERICAL MODEL; POLYMER; PROTEIN;

CARBOXY TERMINAL SEQUENCE; DRUG MARKETING; DRUG METABOLISM; DRUG TARGETING; DRUG UPTAKE; GENETIC ENGINEERING; HEPATITIS C; HUMAN; HYDRODYNAMICS; MICROVASCULATURE; NONHUMAN; PHARMACEUTICAL ENGINEERING; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN POLYMERIZATION; SHORT SURVEY; SYSTEMIC CIRCULATION; TUMOR;

ANIMALS; DRUG DESIGN; HUMANS; INTERFERON ALFA-2A; MICE; NEOPLASMS; POLYETHYLENE GLYCOLS; POLYMERS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 78049375087     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/4671051a     Document Type: Short Survey

References (8)

1. Leader, B., Baca, Q. J. & Golan, D. E. Nature Rev. Drug Discov. 7, 21-39 (2008).
2. Gao, W., Liu, W., Christensen, T., Zalutsky, M. R. & Chilkoti, A. Proc. Natl Acad. Sci. USA 107, 16432-16437 (2010).
3. Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T. & Davis, F. F. J. Biol. Chem. 252, 3582-3586 (1977).
4. Duncan, R. Nature Rev. Drug Discov. 2, 347-360 (2003).
5. Duncan, R. Nature Rev. Cancer 6, 688-701 (2006).
6. Veronese, F. M. & Pasut, G. Drug Discov. Today 10, 1451-1458 (2005).
7. Bailon, P. et al. Bioconj. Chem. 12, 195-202 (2001).
8. Gao, W. et al. Proc. Natl Acad. Sci. USA 106, 15231-15236 (2009).